MHRA (UK)

MHRA authorises plozasiran (Redemplo) for adults with familial chylomicronaemia syndrome

October 19, 2026

Original source summary

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 October 2026, authorised plozasiran (Redemplo)

Verbatim from MHRA (UK)'s own feed — "MHRA authorises plozasiran (Redemplo) for adults with familial chylomicronaemia syndrome"

Want more like this?

Browse more from the feed. A free account unlocks the full feed, saving and communities.